| scholarly article | Q13442814 |
| P50 | author | Mohammad Jakir Hosen | Q42844882 |
| P2093 | author name string | Anne De Paepe | |
| Olivier M Vanakker | |||
| P2860 | cites work | Hypothesizing that histone deacetylase inhibitors can be used to reverse multiple drug resistance | Q39809494 |
| Hypermethylation of the ABCB1 downstream gene promoter accompanies ABCB1 gene amplification and increased expression in docetaxel-resistant MCF-7 breast tumor cells | Q39918721 | ||
| Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2). | Q39985323 | ||
| Epigenetic changes to the MDR1 locus in response to chemotherapeutic drugs | Q40386853 | ||
| Identification of a DNA methylation-dependent activator sequence in the pseudoxanthoma elasticum gene, ABCC6. | Q40448073 | ||
| Serum factors from pseudoxanthoma elasticum patients alter elastic fiber formation in vitro | Q41213819 | ||
| ABCC6 is a basolateral plasma membrane protein. | Q41844790 | ||
| Subcellular localization and N-glycosylation of human ABCC6, expressed in MDCKII cells | Q42046956 | ||
| Expression of the Abca-subfamily of genes in Abcc6-/- mice--upregulation of Abca4. | Q42063856 | ||
| Response to Pomozi et al's research commentary | Q42332712 | ||
| CFTR2: How will it help care? | Q44217225 | ||
| Adenosine triphosphate-binding cassette transporter genes up-regulation in untreated hepatocellular carcinoma is mediated by cellular microRNAs. | Q45873421 | ||
| Oxidative stress in fibroblasts from patients with pseudoxanthoma elasticum: possible role in the pathogenesis of clinical manifestations | Q46784657 | ||
| Vascular endothelial growth factor gene polymorphisms as prognostic markers for ocular manifestations in pseudoxanthoma elasticum | Q47686422 | ||
| Novel clinico-molecular insights in pseudoxanthoma elasticum provide an efficient molecular screening method and a comprehensive diagnostic flowchart. | Q49034771 | ||
| Low serum vitamin K in PXE results in defective carboxylation of mineralization inhibitors similar to the GGCX mutations in the PXE-like syndrome. | Q49107453 | ||
| Molecular docking characterizes substrate-binding sites and efflux modulation mechanisms within P-glycoprotein. | Q50876954 | ||
| Transportomics: screening for substrates of ABC transporters in body fluids using vesicular transport assays. | Q52729873 | ||
| Gene expression profiling of ABC transporters in dermal fibroblasts of pseudoxanthoma elasticum patients identifies new candidates involved in PXE pathogenesis. | Q54511642 | ||
| Protein complexes take the bait | Q59073296 | ||
| Residual chloride secretion in intestinal tissue of deltaF508 homozygous twins and siblings with cystic fibrosis. The European CF Twin and Sibling Study Consortium | Q73977763 | ||
| Seeking modifier genes in cystic fibrosis | Q78850517 | ||
| Involvement of MRP4 (ABCC4) in the luminal efflux of ceftizoxime and cefazolin in the kidney | Q79896496 | ||
| SPP1 promoter polymorphisms: identification of the first modifier gene for pseudoxanthoma elasticum | Q80032873 | ||
| ABCC6 mutations in Italian families affected by pseudoxanthoma elasticum (PXE) | Q80811249 | ||
| P-glycoprotein-deficient mice have proximal tubule dysfunction but are protected against ischemic renal injury | Q81241298 | ||
| Estimation of the three-dimensional pharmacophore of ligands for rat multidrug-resistance-associated protein 2 using ligand-based drug design techniques | Q81556537 | ||
| ABCG2 is a high-capacity urate transporter and its genetic impairment increases serum uric acid levels in humans | Q82761397 | ||
| ABCA1 gene promoter DNA methylation is associated with HDL particle profile and coronary artery disease in familial hypercholesterolemia | Q83654355 | ||
| Analysis of MMP2 promoter polymorphisms in patients with pseudoxanthoma elasticum | Q84391839 | ||
| A mass spectrometry based functional assay for the quantitative assessment of ABC transporter activity | Q84586478 | ||
| CLC-2 single nucleotide polymorphisms (SNPs) as potential modifiers of cystic fibrosis disease severity | Q21261465 | ||
| Mutation detection in the ABCC6 gene and genotype-phenotype analysis in a large international case series affected by pseudoxanthoma elasticum | Q24648254 | ||
| Pseudoxanthoma elasticum: a clinical, pathophysiological and genetic update including 11 novel ABCC6 mutations | Q24674089 | ||
| MicroRNAs: small RNAs with a big role in gene regulation | Q27860896 | ||
| Mutations in a gene encoding an ABC transporter cause pseudoxanthoma elasticum | Q28118435 | ||
| Mutations in ABCC6 cause pseudoxanthoma elasticum | Q28145590 | ||
| Pseudoxanthoma elasticum: Point mutations in the ABCC6 gene and a large deletion including also ABCC1 and MYH11 | Q28204843 | ||
| ABCC6 localizes to the mitochondria-associated membrane | Q28271377 | ||
| The role of ABC transporters in drug resistance, metabolism and toxicity | Q28283237 | ||
| Regulatory pathways for ATP-binding cassette transport proteins in kidney proximal tubules | Q28390004 | ||
| Transport function and hepatocellular localization of mrp6 in rat liver | Q28572742 | ||
| ABCC6 expression is regulated by CCAAT/enhancer-binding protein activating a primate-specific sequence located in the first intron of the gene | Q28710487 | ||
| Exome sequencing of extreme phenotypes identifies DCTN4 as a modifier of chronic Pseudomonas aeruginosa infection in cystic fibrosis | Q30452653 | ||
| Shifting the paradigm: the putative mitochondrial protein ABCB6 resides in the lysosomes of cells and in the plasma membrane of erythrocytes | Q30467294 | ||
| The ERK1/2-hepatocyte nuclear factor 4alpha axis regulates human ABCC6 gene expression in hepatocytes | Q34003799 | ||
| Modifier genes in mice and humans | Q34188131 | ||
| Gene mutation in microRNA target sites of CFTR gene: a novel pathogenetic mechanism in cystic fibrosis? | Q34653919 | ||
| Generalized arterial calcification of infancy and pseudoxanthoma elasticum can be caused by mutations in either ENPP1 or ABCC6 | Q35671719 | ||
| Chloride conductance and genetic background modulate the cystic fibrosis phenotype of Delta F508 homozygous twins and siblings | Q36042699 | ||
| On the putative co-transport of drugs by multidrug resistance proteins | Q36357084 | ||
| Strategies for identifying modifier genes in cystic fibrosis | Q36698814 | ||
| Genetic influences on cystic fibrosis lung disease severity | Q36785547 | ||
| Clinical and molecular characterization of the potential CF disease modifier syntaxin 1A. | Q37316972 | ||
| The macrophage cholesterol exporter ABCA1 functions as an anti-inflammatory receptor | Q37431941 | ||
| ABCC2/Abcc2: a multispecific transporter with dominant excretory functions. | Q37677056 | ||
| Structural and functional properties of human multidrug resistance protein 1 (MRP1/ABCC1). | Q37818370 | ||
| Role of ABC transporters in lipid transport and human disease | Q38082105 | ||
| Circulating miRNAs as sensitive and specific biomarkers for the diagnosis and monitoring of human diseases: promises and challenges | Q38096703 | ||
| Regional variations in ABC transporter expression along the mouse intestinal tract | Q38346757 | ||
| Regulation of cystic fibrosis transmembrane conductance regulator by microRNA-145, -223, and -494 is altered in ΔF508 cystic fibrosis airway epithelium | Q39189253 | ||
| P304 | page(s) | 203 | |
| P577 | publication date | 2013-10-16 | |
| P1433 | published in | Frontiers in Genetics | Q2499875 |
| P1476 | title | The ABCC6 transporter: what lessons can be learnt from other ATP-binding cassette transporters? | |
| P478 | volume | 4 |
| Q48133234 | ABCC6 plays a significant role in the transport of nilotinib and dasatinib, and contributes to TKI resistance in vitro, in both cell lines and primary patient mononuclear cells |
| Q34013439 | ABCC6- a new player in cellular cholesterol and lipoprotein metabolism? |
| Q93369365 | Dietary Pyrophosphate Modulates Calcification in a Mouse Model of Pseudoxanthoma Elasticum: Implication for Treatment of Patients |
| Q26798431 | From variome to phenome: Pathogenesis, diagnosis and management of ectopic mineralization disorders |
| Q36427010 | In vitro and in vivo downregulation of the ATP binding cassette transporter B1 by the HMG-CoA reductase inhibitor simvastatin |
Search more.